AMRX Amneal expands iohexol injection portfolio with U.S. FDA approval of additional strengths and presentations Amneal Pharma - to launch n
AMRX Amneal expands iohexol injection portfolio with U.S. FDA approval of additional strengths and presentations Amneal Pharma - to launch new iohexol injection products in Q3 2026
Story updates
12:15:12 PM UTC
SquawkNews
Amneal Pharmaceuticals...
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.